As of Apr 24
| -0.24 / -3.27%|
The 6 analysts offering 12-month price forecasts for Pernix Therapeutics Holdings Inc have a median target of 14.50, with a high estimate of 19.00 and a low estimate of 8.50. The median estimate represents a +104.51% increase from the last price of 7.09.
The current consensus among 7 polled investment analysts is to Buy stock in Pernix Therapeutics Holdings Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.